Skip to content
Review Open access

Oxford Nanopore Sequencing, a Promising Technology for Precision Diagnostics in Intensive Care Units: A Narrative Review

Aug 2026 · Biomedicines · Vol 14, pp. 1910 · 0 citations · 85 references
Medicine

TL;DR

Nanopore sequencing technology represents a promising molecular diagnostic tool, but wider clinical implementation warrants further larger studies with clinical outcome endpoints, standardized bioinformatic pipelines, and clearer validation pathways.

Abstract

Background: Precision diagnostics are more and more important in intensive care units (ICUs), where rapid identification of infectious agents and antimicrobial resistance determinants is crucial for timely and appropriate treatment. Conventional microbiological methods are frequently limited by long turnaround times and reduced sensitivity, which may delay appropriate treatment. Nanopore sequencing allows rapid, direct, and long-read sequencing of DNA/RNA molecules without the need for amplification, avoiding biases introduced by NGS during amplification and library preparation and generating data in real time. Objectives: This narrative review aims to summarize current knowledge of nanopore technology in the ICU, discuss nanopore principles and current clinical applications in intensive care medicine, highlight its advantages and limitations, and explore future perspectives for integrating nanopore-based diagnostics into precision critical care. Methods: A literature search was performed using PubMed and Web of Science. The literature search was conducted with no lower restriction, covering English-language publications. Results: Nanopore sequencing enables real-time, long-read, single-molecule analysis of native nucleic acid molecules, rapid pathogen identification, antimicrobial resistance profiling, metagenomic analysis, and direct sequencing without amplification. Recent studies have proved the clinical utility of nanopore sequencing in critically ill patients with sepsis, bloodstream infections, hospital-acquired pneumonia, ventilator-associated pneumonia, and fungal and viral infections. Its portability, rapid turnaround time, and potential for point-of-care implementation make it particularly attractive for ICU settings. Conclusions: Nanopore sequencing technology represents a promising molecular diagnostic tool, but wider clinical implementation warrants further larger studies with clinical outcome endpoints, standardized bioinformatic pipelines, and clearer validation pathways.

Read PDF

Similar papers

Review Open access Sep 2026

Nanopore sequencing in infectious disease diagnostics and surveillance

ABSTRACT The global burden of infectious disease is on the rise, driven by antibiotic resistance, emerging pathogens, and gaps in accessible, decentralized diagnostics. To address these demands, there is a need for the development of diagnostic platforms for detection, surveillance, or monitoring assays with quick turn...

Adithi Somayaji, P. Mukherjee, Caroline Koch et al. · 0 citations
Review Open access 2026

Nanopore Sequencing-Based Metagenomic Diagnosis of Culture-Negative Sepsis in Low-Resource Intensive Care Units

The evidence demonstrated the capacity of ML to identify clinically relevant resistance patterns; however, differences in datasets, endpoints, and validation strategies limited direct comparison and quantitative pooling.

A. B. Olanrewaju, J. Abdullahi, Ochuele Dominic Agida et al. · 0 citations
Review Open access Sep 2026

Molecular point-of-care: technological evolution, clinical applications, and future perspectives

The landscape of clinical diagnostics is undergoing a fundamental shift from centralized laboratories toward decentralized point-of-care testing (POCT) models. Conventional molecular diagnostics often suffer from prolonged turnaround times, high operational costs, and a strict reliance on sophisticated infrastructure....

Dan-Feng Zhang, Xin Cui, Rui-Ling Zhang et al. · 0 citations
Oct 2026

Nanopore sequencing of cell-free DNA

Marie Korabečná, Pavel Šenkyřík, Ondřej Brzoň et al. · 0 citations
Open access Oct 2026

Clinical Accuracy and Operational Evaluation of a Novel Nanopore Based 16S Diagnostic Pathogen Detection Workflow.

Culture-based methods remain standard practice for pathogenic bacterial detection in routine diagnostic laboratories but frequently fail to identify pathogens, particularly in low bacterial burden or antibiotic-exposed samples. While full-length 16S rRNA sequencing improves detection and taxonomic resolution, its adopt...

Tom Saville, Magdalena Dąbrowska, Pei-Jun Zhang et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.